Article Information
History
- February 3, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Emma Lott, ASa,
- Darcy Fehlings, MDb,
- Rose Gelineau-Morel, MDd,
- Michael Kruere,
- Jonathan W. Minkc,
- Sruthi P. Thomas, MD, PhDf,
- Steve Wisniewskig,
- Bhooma Aravamuthan, MD DPhila,* and
- the Cerebral Palsy Research Networkh
- aDivision of Pediatric Neurology, Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA
- bDivision of Developmental Paediatrics, Department of Paediatrics, Holland Bloorview Kids Rehabilitation Hospital, University of Toronto, Toronto, Ontario, Canada
- cPittsford, NY, USA
- dDivision of Neurology, Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Children’s Mercy Kansas City, Kansas City, MO, USA
- eBarrow Neurological Institute, Phoenix Children’s Hospital, Departments of Child Health, Cellular and Molecular Medicine, Genetics, and Neurology, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA
- fH. Ben Taub Department of Physical Medicine and Rehabilitation and Departments of Neurosurgery and Pediatrics, Baylor College of Medicine, Houston, TX, USA
- gDepartment of Epidemiology, Epidemiology Data Center, University of Pittsburgh, Pittsburgh, PA, USA
- hThe Cerebral Palsy Research Network, Salt Lake City, UT, USA
- ↵*Address correspondence to: Dr. Bhooma R. Aravamuthan, Division of Pediatric Neurology, Department of Neurology Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8111 St. Louis MO 63110-1093, [aravamuthanb{at}wustl.edu] 314-454-6120
Posted February 03, 2024.
Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral Palsy
